Latest News for: biogenic
Edit
Biogen to Participate in the TD Cowen 46th Annual Health Care Conference (Biogen Inc)
Public Technologies 24 Feb 2026
Cambridge, MA, -- Biogen Inc ... To access the live webcast, please visit the Investors section of Biogen's website at investors.biogen.com ... About Biogen ... We routinely post information that may be important to investors on our website at www.biogen.com.
Edit
Biogenic Solutions Expands Medical Waste Services in Oklahoma for Small and Mid-Size Healthcare Facilities
GetNews 24 Feb 2026
Edit
Statement of Changes in Beneficial Ownership (Form 4) (Biogen Inc)
Public Technologies 18 Feb 2026
) FORM 4. Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b) ... See Instruction 10. UNITED STATES SECURITIES AND EXCHANGE COMMISSION. Washington, D.C ... OMB Number. 3235-0287 ... BIOGEN INC ... Biogen Inc.
Edit
The 5 Most Interesting Analyst Questions From Biogen’s Q4 Earnings Call
The Call 13 Feb 2026
Biogen’s fourth-quarter results were received positively by the market, as the company exceeded Wall Street’s revenue and non-GAAP profit expectations despite a year-over-year decline in sales ... Biogen (BIIB) Q4 CY2025 Highlights..
Edit
Biogen Announces Board Chair Transition
Nasdaq Globe Newswire 11 Feb 2026
Caroline Dorsa to retire from the Biogen Board of Directors; Dr. Maria C. Freire, Director since 2021, elected as new Chair. Caroline Dorsa to retire from the Biogen Board of Directors; Dr. Maria C. Freire, Director since 2021, elected as new Chair ... .
Edit
Notice of Proposed Sale of Securities (Form 144) (Biogen Inc)
Public Technologies 09 Feb 2026
). The text version of this document is not available ... Disclaimer. Biogen Inc.
Edit
Biologics License Application for Subcutaneous Formulation of “LEQEMBI®” (lecanemab) for the Treatment of Early Alzheimer’s Disease Designated for Priority Review in China (Biogen Inc)
Public Technologies 09 Feb 2026
Edit
Biogen Reports Fourth Quarter and Full Year 2025 Results (Biogen Inc)
Public Technologies 06 Feb 2026
). Stockholder Communications. Attachments Original document Permalink ... Biogen Inc.
Edit
Q4 and Full Year 2025 Biogen Earnings Presentation (Biogen Inc)
Public Technologies 06 Feb 2026
Edit
Biogen’s (NASDAQ:BIIB) Q4 CY2025: Strong Sales
The Call 06 Feb 2026
Biotech company Biogen (NASDAQ ... Is now the time to buy Biogen? Find out by accessing our full research report, it’s free. Biogen (BIIB) Q4 CY2025 Highlights. ... Biogen’s demand was weak over the last five years as its sales fell at a 6% annual rate.
Edit
Biogen reports strong fourth quarter and full year 2025 results and provides full year 2026 financial guidance (Form 8-K) (Biogen Inc)
Public Technologies 06 Feb 2026
) Biogen reports strong fourth quarter and full year 2025 results and provides full year 2026 financial guidance ... Biogen Inc ... ET on February 6, 2026 and will be accessible through the Investors section of Biogen's website, www.biogen.com ... About Biogen.
Edit
Biogen (BIIB) Q4 Earnings Preview: The "New Biogen" Emerges as Alzheimer's and Rare Disease Pipelines Take Center Stage
The Call 06 Feb 2026
Edit
Biogen (BIIB) Deep Dive: Navigating the Pivot from MS Giant to Neuro-Innovation Powerhouse
The Call 06 Feb 2026
As of February 6, 2026, Biogen Inc ... With a significant quarterly earnings beat reported just today, the market is beginning to weigh whether the "New Biogen" is finally ready to reward patient long-term investors.
- 1
- 2
- Next page »